CORD-19:e847d433e7424152a9846673209cb73027415ecd / 90140-90462
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/e847d433e7424152a9846673209cb73027415ecd","sourcedb":"CORD-19","sourceid":"e847d433e7424152a9846673209cb73027415ecd","text":"The T.E.S.T. program determined the in vitro activity of tigecycline against strains of Enterobacteriaceae cross-resistant to one or more of the following antimicrobials: amoxicillin-clavulanic acid, piperacillin-tazobactam, levofloxacin, ceftriaxone, cefepime, ampicillin, amikacin, minocycline, ceftazidime and imipenem.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T919","span":{"begin":0,"end":322},"obj":"Sentence"},{"id":"T9852","span":{"begin":0,"end":322},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T919","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T9852","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T472","span":{"begin":0,"end":322},"obj":"Sentence"}],"attributes":[{"subj":"T472","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecb4","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec9a93"}]}]}}